Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.
<h4>Unlabelled</h4>Metformin, a biguanide derivate, has pleiotropic effects beyond glucose reduction, including improvement of lipid profiles and lowering microvascular and macrovascular complications associated with type 2 diabetes mellitus (T2DM). These effects have been ascribed to ad...
Guardado en:
Autores principales: | Antonella Napolitano, Sam Miller, Andrew W Nicholls, David Baker, Stephanie Van Horn, Elizabeth Thomas, Deepak Rajpal, Aaron Spivak, James R Brown, Derek J Nunez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0210c4a3a2ff4b068af2ccf58d9a2e0f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang Q, et al.
Publicado: (2020) -
Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
por: María Molina-Vega, et al.
Publicado: (2022) -
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holl, et al.
Publicado: (2014) -
Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014) -
Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
por: Ivan Sergeevich Kuznetsov, et al.
Publicado: (2013)